Ono Pharmaceutical reports Q1 GAAP EPS of ¥51.38 on revenue of ¥116.1 billion

Seeking Alpha··Read original
2▲0 ▼0Impact / 5
Summary · why it matters

Ono Pharmaceutical reported first-quarter GAAP earnings per share of ¥51.38 and revenue of ¥116.1 billion, according to a company press release. The results were disclosed in the firm's latest financial filing. No further quarterly details were immediately provided.

Impact on assets 1

Biotech & Genomic Medicine▲